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A B S T R A C T
Results of the National Program of Breast Cancer Early Detection in Brod-Posavina County during the 2006–2012
period are presented. Response rate in two National Program cycles, cancers detected according to factors such as first
and last menstruation, age at cancer detection, deliveries and mammography findings according to the Breast Imaging
Reporting and Data System (BI-RADS) before diagnosis verification were analyzed. Data were obtained from the soft-
ware connecting Public Health Institutes via Ministry of Health server and questionnaires filled out by the women pre-
senting for screening and processed by the method of descriptive statistics. Mammography findings were classified ac-
cording to the BI-RADS classification. In two National Program cycles during the 2006–2012 period, women aged 50–69
were called for mammography screening. In the first cycle, the response rate in Brod-Posavina County was 53.2%, with
71 cancers detected at a mean age of 61.3 years. In the second cycle, the response rate was 57.0%, with 44 cancers detected
at a mean age of 62.5 years. In the first and second cycles, there were 21.1% and 14.3% of mammography findings requir-
ing additional work-up (BI-RADS 0), respectively. Particular risk factors such as early menarche, late menopause, par-
ity, positive family history and presence of benign breast lesions were not demonstrated in women with verified cancer.
There was no increase in the incidence of breast cancer per 100,000 inhabitants in the Brod-Posavina County following
implementation of the National Program. In conclusion, efforts should be focused on increasing public health aware-
ness, ensuring appropriate professional staff engaged in screening, and improving medical care in order to reduce the
time elapsed from establishing suspicion to confirming the diagnosis of breast cancer.
Key words: breast neoplasms, women, incidence, mortality, mass screening, mammography, implementation, public
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Introduction
Breast cancer is the most common malignant tumor
and the leading cause of cancer death in women in
Europe1–4. Incidence rates were much higher in more de-
veloped countries compared to less developed countries
(71.7/100,000 and 29.3/100,000, respectively, adjusted to
the World 2000 Standard Population), whereas the corre-
sponding mortality rates were 17.1/100,000 and 11.8/
100,0005. The last three decades have yielded marked
progress in the diagnosis and management of breast can-
cer. Not only is the disease being detected at a much ear-
lier stage, but the addition of systemic therapy has also
improved survival6. In Croatia, breast is also the most
common seat of carcinoma in women. In 2010, the age-
-standardized breast cancer incidence and mortality
rates (standardized for European population) were 81.3
and 27.4, respectively7. The incidence trends of breast,
endometrial and ovarian cancers in Croatia 1988–2008
were similar to the trends observed in most European
countries, while a modest decline in the incidence of cer-
vical cancer and the lack of decline in breast cancer mor-
tality suggest suboptimal cancer prevention and control8.
In Croatia, the breast cancer age-standardized incidence
rates are comparable to those recorded in the surround-
ing countries and considerably lower than those reported
from industrialized European countries. In 2006, the
breast cancer age-standardized incidence rate was 79.4
in Croatia, 79.0 in Bosnia and Herzegovina, 69.2 in Ser-
bia and 87.5 in Slovenia versus 126.5 in Switzerland,
122.2 in Great Britain and 121.2 in Germany. On the
other hand, the standardized mortality rate (per 100,000
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European population) did not show such great differ-
ences according to the level of industrialization (Croatia
26.3, Bosnia and Herzegovina 23.5, Serbia 23.0, Slovenia
28.6, Switzerland 22.8, Great Britain 27.3 and Germany
26.5)1. In Croatia, 2473 new cases of breast cancer were
registered in 2008 and 902 deaths from breast cancer in
2009, making breast cancer the most common cause of
cancer death in women. There is constant increase in the
incidence and mortality of breast cancer in Croatia, how-
ever, with stabilization of the mortality trend in recent
years9. Resolution on Cancer Prevention and Control
adopted by the World Health Organization points to the
need of developing and implementing national programs
(NP) of cancer detection. National programs of cancer
detection are public health projects aimed at reducing
the number of individuals affected with and dying from
cancer, and at improving the quality of life of cancer pa-
tients by systematic and even implementation of evi-
dence-based strategy through optimal utilization of the
resources available10. Therefore, implementation of the
National Program of Breast Cancer Early Detection,
known as Mamma, carried out in Croatia since 2006, is of
utmost public health importance.
Aim
The aim of this report is to present results of the Na-
tional Program of Breast Cancer Early Detection (NP) in
Brod-Posavina County (County) during the 2006–2012
period. Response rate in two NP cycles, cancers detected
according to factors such as age at first and last menstru-
ation, deliveries, age cancer detection, and mammogra-
phy according to the Breast Imaging Reporting and Data
System (BI-RADS) classification before diagnosis verifi-
cation.
Materials and Methods
In the County, the National Program of Breast Cancer
Early Detection (NP) has been conducted by a public
health team from Department of Public Health, Mental
Health Care, Prevention and Outpatient Treatment of
Dependencies of the County Public Health Institute. The
team consists of a physician and a nurse, with the physi-
cian coordinating NP performance throughout the Coun-
ty. In the County, there are two mammography units: one
at Department of Radiology, General Hospital »Dr Josip
Ben~evi}« in Slavonski Brod and the other at General
Hospital in Nova Gradi{ka. The physicians in radiology
units have been authorized by the Commission for Orga-
nization, Surveillance and Quality Control of the Na-
tional Program of Breast Cancer Early Detection to in-
terpret mammography findings and enter them into the
respective software using their access code. Appropriate
quality control requires duplicate independent image
interpretation10. Radiologists performing mammography
have also been appointed for the needs of NP. Concerning
mammography devices, General Hospital in Slavonski
Brod has a GE-PERFORMA-STEREO from 2007, while
General Hospital in Nova Gradi{ka has a 10-year-old
Siemens Mammomat 1000. Upon receiving envelopes
with inviting letters and educational leaflets from the
Ministry of Health, the public health team makes a list of
women to call for examination and set the screening
dates in collaboration with the radiology unit. Thus, ev-
ery woman of the above mentioned age group receives
the inviting letter with the date of mammography
screening, educational material and a sort of referral
slip. Any additional information, change of mammogra-
phy date, etc. are available at the Public Health Institute
free telephone number. All data collected are entered in
the program to update the list of women anticipated for
calling for mammography screening. Based on the 2001
census, at starting the NP (cycle 1), there were 26,419
women aged 50–69 to be called for screening in the
County. In NP cycle 2 performed after 2–3 years, the
number of women was reduced by updating the registry,
which included changing the place of residence, deaths,
women diagnosed with breast cancer, women at an in-
creased risk and already under medical treatment, etc.;
thus, 25,022 women were eligible for calling to screening
in NP cycle 2. Women born in 1937 to 1958 were invited
from the end of 2006 to 2009, but not by years in order.
Those born in 1937 were invited first. In cycle 2, women
were re-invited by the same order, whereby the women
having reached 70 were not included anymore, while
those having reached 50 entered the program. Re-invit-
ing the same women for screening after 2–3 years was
completed at the end of 2011.
In addition, members of the public health team col-
lected data on women diagnosed with breast cancer from
all resources available (records forms, statistical forms,
findings and all information on additional diagnostic
work-up and therapy for a particular woman) and en-
tered them in the program carcinoma base. Results were
analyzed using the software connecting all public health
institutes with the Ministry of Health server. The soft-
ware offers Reports on the National Program of Breast
Cancer Early Detection implementation and BI-RADS
List by Mammography Units. Questionnaires filled-out
by each woman on presenting for screening were also in-
cluded in the analysis. The mean and standard deviation
were calculated for numerical parameters. The response
rate in Slavonski Brod, Nova Gradi{ka and County as a
whole was calculated from the above mentioned Report
by counting up all women that failed to present for
screening for any reason and calculating their percent-
age of all women invited. On presenting for screening,
the women present the questionnaire containing data
that may influence carcinoma development. The analysis
included the risk factors stated in the questionnaire, i.e.
data on menarche, age at last menstruation, family his-
tory, benign breast lesions and number of deliveries.
Results
In NP cycle 1, all anticipated women (N=26,419)
were invited for screening in the County, with a response
rate of 53.2%, 71 cases of breast cancer detected and veri-
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fied, and rate of newly detected breast cancer per 1000
screened women of 5.7 for all age groups. In Slavonski
Brod, the response rate was 55.2% and in Nova Gradi{ka
51.2%. The response rate varied according to age groups,
being highest in the oldest age group of ³70 (56.5%), fol-
lowed by the 60–64 age group (54.8%). In cycle 2, all an-
ticipated women were re-invited (N=25,022). The Coun-
ty response rate was 57.0%, with 44 new cases of breast
cancer detected and verified, and the rate of newly de-
tected cases per 1000 screened women of 3.9. The re-
sponse rate in Slavonski Brod and Nova Gradi{ka was
56.5% and 57.5%, respectively. The response rate varied
again according to age groups, being highest in the oldest
age groups of 65–69 (59.5%) and ³70 (63.8%). In cycle 1,
the highest percentage of women with verified breast
cancer was found in the 65–69 age group (32.4%), with
the mean age at cancer detection of 61.3. In cycle 2, the
highest percentage of women with verified breast cancer
was found in the 50–54 age group (29.5%), with the mean
age at cancer detection of 62.5 (Table 1).
In cycle 1, 14,021 women failed to respond to the call
for screening in the County; 9781 (69.8%) of them pro-
vided no explanation for it. There were 1835 incorrect
addresses and 214 women temporarily living elsewhere.
In cycle 2, 13,799 women failed to respond to the call for
screening in the County; 82.4% of them provided no ex-
planation, while incorrect addresses or living elsewhere
were the causes in 9.8% of cases; 330 women had died, 82
of them with carcinoma (Table 2).
In the BI-RADS List by Mammography Units report,
12,406 mammography findings were analyzed for the
County in cycle 1, with 21.1% of these requiring addi-
tional work-up; 33.1% of normal findings; 40% of benign
findings requiring no additional work-up; 4.9% of proba-
bly benign findings with recommended follow up in 6
months; 0.8% of suspect lesions; and 0.06% of highly sus-
pect malignant lesions. In cycle 2, 11,223 mammography
findings were analyzed for the County as a whole, with
14.3% of findings requiring additional work-up; 26.5% of
normal findings; 46.4% of benign findings; 11.7% of
probably benign findings; 1.1% of suspect lesions; and
0.03% of highly suspect malignant lesions (Table 3).
The age at first menstruation was analyzed from the
questionnaires filled-out by the women. In cycle 1 and cy-
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TABLE 1
THE RESPONSE RATE AND NUMBER OF CARCINOMA DETECTION ACCORDING THE AGE GROUPS
Age
groups
Slavonski Brod Nova Gradi{ka County
Cycle 1 Cycle 2 Cycle 1 Cycle 2 Cycle 1 Cycle 2
RR – (%) BC RR – (%) BC RR – (%) BC RR – (%) BC RR – (%) BC RR – (%) BC
50–54 48.4 11 51.4 7 45.2 6 49.8 3 46.8 17 50.6 10
55–59 54.0 7 53.5 6 54.2 8 57.6 6 54.1 15 55.6 12
60–64 54.7 8 54.2 6 54.9 3 56.8 2 54.8 11 55.5 8
65–69 57.9 12 59.7 7 49.7 5 59.2 3 53.8 17 59.5 10
³70 60.8 10 63.7 4 52.1 1 64.1 0 56.5 11 63.8 4
Total 55.2 48 56.5 30 51.2 23 57.5 14 53.3 71 57.0 44
RR – response rate, BC – breast carcinoma
TABLE 2
REASON OF FAILED TO RESPOND TO THE CALL FOR SCREENING
Reasons
Slavonski Brod Nova Gradi{ka County
Cycle 1 Cycle 2 Cycle 1 Cycle 2 Cycle 1 Cycle 2
N % N % N % N % N % N %
Change of date + absence 40 0.4 33 0.3 14 0.3 17 0.4 54 0.4 50 0.4
Examined before 12 months 760 7.7 408 4.2 345 8.3 163 3.9 1105 7.9 571 4.1
Already diagnosed 153 1.6 57 0.6 90 2.2 25 0.6 243 1.7 82 0.5
Other reasons 69 0.7 23 0.2 27 0.6 3 0.1 96 0.7 26 0.2
Do not want 92 0.9 15 0.2 69 1.7 10 0.2 161 1.1 25 0.2
Deceased 368 3.7 247 2.6 164 3.9 83 2.0 532 3.8 330 2.4
Failed to call / no explanation 7248 73.6 8023 83.5 2533 60.7 3341 79.7 9781 69.8 11364 82.4
Incorrect addresses 1000 10.2 717 7.5 835 20.0 521 12.4 1835 13.1 1238 9.0
Temporary living elsewhere 116 1.2 82 0.9 98 2.3 31 0.7 214 1.5 113 0.8
Total 9846 100.0 9605 100.0 4175 100.0 4194 100.0 14021 100.0 13799 100.0
cle 2, the mean age at first menstruation was 13.7 and
13.5 years, and the mean age at last menstruation 49.4
and 50.0 years, respectively. The mean number of deliv-
eries was 2.3 in cycle 1 and 2.2 in cycle 2. In cycle 1 and
cycle 2, the mean age at carcinoma detection was 61.2
and 61.1 years, respectively (Table 4a). Positive family
history was recorded in 7 women diagnosed with carci-
noma in cycle 1 and 6 women in cycle 2, while 22 women
in cycle 1 and 10 women in cycle 2 mentioned benign
breast lesions in their personal history (Table 4b).
Discussion
The National Program of Breast Cancer Early Detec-
tion has been conducted by screening, using mammogra-
phy as the method recommended by the European Union
for women aged 50–69. Screening is performed every 2–3
years for all women of this age irrespective of the place of
residence, social status and level of education, health in-
surance, etc. By definition, screening includes asympto-
matic and average-risk population. The women having
symptoms or positive family history should undergo a
different examination algorithm from younger age. How-
ever, the women with positive family history not previ-
ously submitted to appropriate work-up are covered by
screening, entering a respective note in the question-
naire to be filled-out when presenting for screening. The
main purpose of screening mammography is detection of
clinically occult breast cancer, which is still small and in
the early stage of development11. Some 90% of breast
cancers are considered to be curable if timely detected,
and mammography can detect lesions for up to two years
before they become palpable. It takes 5–8 years for the
tumor to grow to 1 cm diameter, and it is when it can be
clinically detected by palpation12. Detection of breast
cancer in a stage when it is still curable, along with 25%
reduction in the related mortality rate in the next 5 years
and improvement in the patient quality of life is one of
the NP goals. In Croatia, the Mamma NP has been con-
ducted since October 2, 2006. During 3 years (from Octo-
ber 2006 to September 2009) in cycle 1, the response rate
was 58.5% of 720,981 women invited, with more than
1500 cases of breast cancer detected10. In Brod-Posavina
County, the response rate in cycle 1 was 53.2% of 26,419
women invited. At the national level, cycle 1 termination
was proclaimed by the Commission for NP implementa-
tion and National Coordinators. In cycle 2, which started
in September 2009 and lasted until the end of 2011, the
response rate was 57.0% of 25,022 women invited. Total
response rate in the County in the two cycles was by far
lower than expected (70%) according to the Ministry of
Health guidelines, thus one of the three main goals was
not reached13. The response rate was below the accept-
able rate of 70% or desirable rate of 75% according to the
European Guidelines for Quality Assurance in Breast
Cancer Screening14. The response rate in cycle at the na-
tional level was 58.5%, although in some counties it ex-
ceeded the set rate of 70% (e.g., Me|imurje County
81.3%, Bjelovar-Bilogora County 78.5% and Po`ega-Sla-
vonija County 74.7%)10. In cycle 1, a response rate lower
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TABLE 3
MAMMOGRAPHY FINDINGS ACCORDING TO BI-RADS CLASSIFICATION
BI-RADS
Slavonski Brod Nova Gradi{ka County
Cycle 1 Cycle 2 Cycle 1 Cycle 2 Cycle 1 Cycle 2
N % N % N % N % N % N %
0 2572 30.7 1545 19.5 47 1.2 58 1.8 2619 21.1 1603 14.3
1 2568 30.7 2047 25.8 1539 38.2 931 28.2 4107 33.1 2978 26.5
2 2707 32.3 3212 40.5 2256 56.0 1994 60.5 4963 40.0 5206 46.4
3 456 5.4 1026 12.9 159 3.9 285 8.6 615 4.9 1311 11.6
4 71 0.8 96 1.2 23 0.6 26 0.8 94 0.8 122 1.1
5 3 0.1 1 0.1 5 0.1 2 0.1 8 0.1 3 0.1
Total 8377 100.0 7927 100.0 4029 100.0 3296 100.0 12406 100.0 11223 100.0
TABLE 4 A




Cycle 1 Cycle 2
Menarche (year) 13.7 (4.2) 13.5 (4.2)
Deliveries (number) 2.3 (4.2) 2.2 (2.1)
Menopause (year) 49.4 (10.6) 50.0 (12.7)
Cancer detected (year) 61.2 (14.9) 61.1 (14.1)
TABLE 4 B
PRESENCE OF RISK FACTORS (DESCRIPTIVE)
Risk factors
Yes No
Cycle 1 Cycle 2 Cycle 1 Cycle 2
Positive family history 7 6 64 38
Breast lesion 22 10 49 34
than expected was also recorded in Dubrovnik-Neretva
County (59.5%)15. We also analyzed the reasons for not
presenting for screening (Table 2). The great majority of
women that did not present for screening also failed to
call the free telephone to explain the reason for their lack
of response, pointing to the lack of interest in the screen-
ing. The percentage of these women was 37% in cycle 1
and even more, 45.4% in cycle 2. In Dubrovnik-Neretva
County, there were 35.6% of women with unavailable in-
formation on the reason for their lack of response15. We
presumed the proportion of women not responding to the
call for screening to be lower in cycle 2, however, the
analysis revealed the opposite. Such a result was unex-
pected considering the length of NP implementation
along with sensitization and education of the public at
large on its performance and associated benefit. In this
part of the NP, general practitioners and visiting nurses
should have the key role in motivation and education of
women. In cycle 1 and cycle 2, there were 6.9% and 4.9%
of incorrect addresses, respectively, obviously requiring
NP updating with recent residence data. The NP base of
target women was based on the data received from the
Ministry of Internal Affairs (place of residence) and Cro-
atian Institute of Health Insurance (respective general
practitioner). The Brod-Posavina County is one of the
counties with their territory partially occupied during
the war, thus a certain number of women have been liv-
ing elsewhere since the post-war period. We presumed
that the response rate would therefore be lower in the
area of Nova Gradi{ka because it was partially occupied
during the war; however, the results showed that it was
not true (Table 2). As the public health team has col-
lected and processed health statistics forms, here we
present the following forms with the diagnosis C50 –
Breast Cancer: Malignant neoplasm report; Hospital sta-
tistics form; Histopathology finding; and Death certifi-
cate; all data were updated in the NP. These procedures
contribute to data accuracy and supplement computer
updating with death databases, Cancer Registry data-
base, etc. Mammography finding was described by the ra-
diologist according to the BI-RADS classification, issued
by the American College of Radiology. This system helps
in standardization of findings and provides recommenda-
tions for further work-up, and it is obligatory in North
America and ever more in Europe11. The BI-RADS classi-
fication was introduced at NP launching. In cycle 1,
12,406 mammography findings were analyzed according
to BI-RADS classification, i.e. 8377 in Slavonski Brod
and surrounding communities, and 4029 in Nova Gra-
di{ka and surrounding communities (Table 3). The anal-
ysis yielded 21.1% of findings with BI-RADS 0 (30.7% in
Slavonski Brod and 1.2% in Nova Gradi{ka). According
to BI-RADS classification, 0 finding means that addi-
tional examination or comparison with previous mam-
mography findings is needed. The strikingly higher pro-
portion of BI-RADS 0 findings in Slavonski Brod (30.7%)
compared with Nova Gradi{ka with only 1.2% of BI-
-RADS 0 findings points to differences in the interpreta-
tion of findings between particular mammography units.
In cycle 2, a total of 11,223 mammography findings were
analyzed according to BI-RADS classification; 14.3% of
findings required additional work-up (BI-RADS 0), again
with considerable difference between Slavonski Brod and
Nova Gradi{ka (19.5% vs. 1.8%) (Table 3). The propor-
tion of BI-RADS 0 findings had decreased considerably in
Slavonski Brod, suggesting that the experience of radiol-
ogists had improved with time and interpretation of ever
more findings during screening. It should also be noted
that the BI-RADS 0 category is usually employed on
mammography screening, while it is rarely used on diag-
nostic mammography. Impossibility of comparison with
previous mammography findings poses a major problem
to radiologists. In the NP, the envelopes and their content
were limited to the weight of only one set of mammogra-
phy findings, thus preventing comparison of findings and
increasing considerably the rate of BI-RADS 0 findings.
The number of these findings was too high in Slavonski
Brod and too low in Nova Gradi{ka. This drawback
should be corrected in the future to make these values
closer to each other. The possibility of sending previous
findings for comparison should be introduced at the na-
tional level, which would greatly reduce the number of
BI-RADS 0 findings, while increasing those of BI-RADS 2
and 3 categories. In Dubrovnik-Neretva County, there
were 11.1% of BI-RADS 0 findings15, just like our 30% in
Slavonski Brod exceeding the acceptable <7% according
to European guidelines14. The rate of mammography
findings requiring repeat examination and classified as
BI-RADS 0 (so-called recall rate) is one of the main fac-
tors in the mammography screening quality control15. In
cycle 1, 71 cancers were verified by the additional work-
-up recommended, accounting for 0.05% of all women
presenting for screening and yielding a rate of newly de-
tected breast cancer of 5.7/1000 examined women. In cy-
cle 2, 44 cancers were verified by diagnostic work-up, ac-
counting for 0.3% of all responding women and yielding a
rate of 3.9/1000 examined women. The rates of newly de-
tected breast cancer in the Brod-Posavina County (1.8–
10.1/1000) were consistent with literature data15. At the
time of diagnosis, 4 women were aged 71 and one woman
was aged 72 due to the time needed for follow up and
data processing. According to NP, women with suspect
findings should undergo complete diagnostic work-up
within one month16. From the questionnaires filled-out
by women on their presenting for screening, data on the
age at menarche, last menstruation, number of deliveries
and family history were analyzed. Besides these risk (or
protective) factors, the age at cancer detection and his-
tory data on benign breast lesions were recorded (Table
4a and 4b) and compared with literature reports. Accord-
ing to literature data, the length of reproductive age, i.e.
the risk of breast cancer increases with prolonged effect
of circulating estrogen17,18, early menarche and late
menopause19. Although younger age at menarche is con-
sidered to be associated with an increased risk of breast
cancer, this risk varies according to the type of tumor
with positive or negative estrogen receptors20. In our
women, the mean age at menarche was around 13 years
in both cycles; based on literature data, the women with
verified breast cancer did not belong to those at an in-
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creased risk or were at the risk borderline. Late meno-
pause increases the risk of breast cancer; in women with
menopause at age 55 are at a twofold risk of developing
breast cancer recorded in women with menopause at age
45. In women with breast cancer detected, the last men-
struation was recorded at age 50 on average; 90% of
women in cycle 1 and 93.2% of women in cycle 2 were in
menopause at the time of cancer diagnosis. Similar to our
results, literature data also show that breast cancer is
most commonly detected in postmenopausal women21,22.
The women from Brod-Posavina County had had 2 deliv-
eries on average, whereas only 8.5% and 4.5% of women
were nulliparae. Some literature data point to the role of
the number of deliveries, whereby a higher number of
deliveries is associated with a lower risk of breast cancer
(as compared with nulliparity)18, however, there also are
opposite reports on the parity and length of breastfeed-
ing having no impact on the occurrence of breast can-
cer23. Our results appear to support the latter statement.
Positive family history was recorded in 9.9% of women in
cycle 1 and 13.6% of women in cycle 2. The information
obtained from the questionnaires did not specify the fe-
male relatives involved (1st or 2nd degree). According to
literature data, however, 85% of women with verified
breast cancer have negative family history, while 85% of
women having a 1st degree relative diagnosed with breast
cancer will never develop breast cancer; besides heredity,
great role is attributed to environmental factors24. Liter-
ature data also point to the important synergy of particu-
lar risk factors25. Thus, individual risk factors should be
observed in association with others, body weight and
body mass index in particular, in order to interpret their
effects more accurately. Body weight and body mass in-
dex were not analyzed in the present study due to the
lack of data on these factors in such a great number of
questionnaires. In our women, history data revealed be-
nign breast lesions in 31.0% and 22.7% of cases in cycle 1
and cycle 2, respectively. Although cycle 1 mammography
findings showed breast lesions according to BI-RADS
classification, the women reported no breast lesions (on-
ly 8 of 34 women were aware of some breast lesions in
their cycle 1 mammography findings). This information
points to the importance of including general practitio-
ners in the screening; namely, when the women receive
the radiologist’s finding by mail, they should visit their
family physician, who will explain them the finding and
give them further instructions. Other authors also point
to the role of general practitioners26,27, suggesting that
the screening should be part of the primary health care
performed together with general practitioners as the
'starting point’. In Croatia, general practitioners have a
minor role and are only included in the program in case
of suspect findings, when referral slips for additional di-
agnostic work-up and therapy are required. The number
of newly detected cases of breast cancer is expected to
rise initially with NP implementation16,1. Data from Can-
cer Registry on the incidence of cancer in Croatia show
an increase a year after the introduction of screening
(2007) in the age groups covered by the screening28. In
the 50–54 age groups, an increase in the incidence of
breast cancer has been recorded since 2007, whereas in
the older age groups the incidence has been on increase
continually since 2006. In the Brod-Posavina County,
data are available for all women aged 0 to ³85, showing
no increase. In 2005 (before screening), the incidence per
100,000 was 103.3, and in 2006 upon the introduction of
screening it was 90.1. An increase to 102.2 was noted
again in 2007 and to 105.5 in 2008. As specific age distri-
bution is not available, it is not possible to determine
whether the incidence of breast cancer has increased in
the age groups covered by screening. Preventive pro-
grams of early cancer detection are justified if leading to
mortality reduction, however, literature data show that
quite different results may be obtained depending on the
type of data analysis, yielding variable values of mortal-
ity reduction (from rather high 25% to only 6%)29. More
than 5 years (7–10 years) should elapse from the begin-
ning of screening to observe the trend in mortality and to
draw valid conclusions; in addition, comparison with the
age groups not included in screening is also required.
Over the past few decades, substantial progress has been
made in diagnosis and treatment of breast cancer30. Also,
other factors such as modification of risk factors and
treatment of the disease have greater impact on mortal-
ity reduction31.
Conclusion
The implementation of the National Program of Breast
Cancer Early Detection in Brodsko-posavska County
should be upgraded at various levels. Some improve-
ments are necessary at the national level, e.g., higher me-
dia promotion, continuous education of the professionals
involved in screening, and inclusion of general practitio-
ners and visiting nurses. Information on residence ad-
dresses, family physicians, deaths and cancer patients
should be accurate and updated. In the County, the cur-
rently low level of public health awareness should be im-
proved; adequate personnel for additional engagement in
screening should be ensured; and medical care should be
upgraded to reduce the time to diagnostic work-up upon
establishing suspicion of breast cancer. Efficiency of the
program cannot be verified due to the relatively short
time of screening performance and certain drawbacks in
systematic evaluation. Women should definitely be in-
formed on all the known advantages and shortcomings of
mammographic screening, but this will require high health
awareness of the public at large for the women to make
the best decision.
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NACIONALNI PROGRAM RANOG OTKRIVANJA RAKA DOJKE U BRODSKO-POSAVSKOJ
@UPANIJI (ISTOK HRVATSKE)
S A @ E T A K
Cilj rada bio je prikazati rezultate Nacionalnog programa za rano otkrivanje raka dojke u Brodsko-posavskoj `upa-
niji, u periodu od 2006. do 2012. godine. Analizirali smo odaziv u dva provedena ciklusa, zatim otkrivene karcinome s
obzirom na ~imbenike poput dobi prve i zadnje menstruacije, starosti `ena u vrijeme otkrivanja karcinoma, porode i
dojenje, te nalaze mamografije prema BI-RADS-u pred potvr|ivanje dijagnoze. Kori{teni su podatci softvera kojim su
povezani Zavodi za javno zdravstvo preko servera Ministarstva zdravlja i anketni upitnici koje `ene ispunjavaju prili-
kom pristupa probiru obra|eni deskriptivnom metodom. Nalazi mamografije razvrstani su prema BI-RADS klasifi-
kaciji. U dva ciklusa pozivanja u periodu od 2006. godine do 2012.godine na probirnu mamografiju pozivane su `ene u
dobi od 50–69 godina. Odaziv za Brodsko-posavsku `upaniju u prvom ciklusu je bio 53,2% i otkriven je 71 karcinom, u
prosje~noj dobi od 61,3 godina. U drugom ciklusu je odaziv bio 57,0 %, a otkriveno je 44 karcinoma u prosje~noj dobi od
62,5 godina. Nalaza mamografije koji zahtijevaju dodatnu obradu (BI-RADS 0) bilo je 21,1% u 1. ciklusu i 14,3% u 2.
ciklusu. Pojedina~ni rizi~ni faktori poput rane menarhe, kasne menopauze, pariteta, pozitivne obiteljske anamneze ili
postoje}ih dobro}udnih promjena na dojkama nisu dokazani kod `ena kojima je potvr|en karcinom. Pove}anje stope
incidencije na 100.000 stanovnika u Brodsko-posavskoj `upaniji nakon uvo|enja Nacionalnog programa nije zabilje`e-
no. Autori zaklju~uju kako je neophodno pove}ati razinu zdravstvene prosvje}enosti, osigurati dostatan kadar za doda-
tnu anga`iranost u provo|enju probira, te pobolj{ati medicinsku skrb kako bi se skratio period od postavljanje sumnje
do potvr|ivanja dijagnoze.
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